Quest Diagnostics Inc (DGX) Stock Price, Quote & News

Company Profile

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 973 520 2700

Website: www.questdiagnostics.com

Address:

500 Plaza Drive, Secaucus, United States

BillionerOfKing Dec. 3 at 3:04 AM

$DGX Current Stock Price: $182.42 Contracts to trade: $180 DGX Dec 19 2025 Call Entry: $4.80 Exit: $7.55 ROI: 57% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Trade2Win2019 Nov. 24 at 11:21 PM

$DGX good short idea right here 🐻📉📉📉🩸

0 · Reply

OfficialStocktwitsUser Nov. 24 at 2:57 PM

$DGX RSI: 74.20, MACD: 2.0364 Vol: 5.47, MA20: 182.87, MA50: 183.42 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

ZacksResearch Nov. 24 at 2:13 PM

$DGX up 17.8% in a year against industry’s 0.1% decline — can the rally continue? 📈 Quest Diagnostics’ strategic acquisitions and investments in advanced diagnostics are driving growth, with an earnings yield above industry average and an average earnings surprise of 2.5% 🔍. However, rising debt and stiff competition pose challenges ⚠️. Discover what could impact DGX's performance next 👉 https://www.zacks.com/stock/news/2794563/should-you-hold-quest-diagnostics-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2794563-body-22185&ADID=SYND_STOCKTWITS_TWEET_2_2794563_BODY_22185

0 · Reply

ZacksResearch Nov. 24 at 1:13 PM

Is $DGX still worth holding while the pressure builds? The company is driving growth through acquisitions and advanced diagnostics, but rising debt and tough competition are weighing on its outlook — a real mixed setup for investors. Full risk/reward rundown here 👉 https://www.zacks.com/stock/news/2794563/should-you-hold-quest-diagnostics-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2794563-teaser-22183&ADID=SYND_STOCKTWITS_TWEET_2_2794563_TEASER_22183

0 · Reply

SPYmyQQQ Nov. 21 at 7:32 PM

🎯 Target Hit 🏁 📨 From Nov 11, 2025 🏛️ $DGX 💵 Entry: $188.8800 ✅ Exit: $193.4320 💰 P/L: +2.41% 👉 FREE TRIAL! spymyqqq/join/

0 · Reply

gaineous Nov. 19 at 3:46 PM

Bullish for 2026 Complete Conviction $AMT $ODD $ONDS $YOU $DGX Above Ave Conviction ATEC DOCU ZM Forever Holds AXP EXPE WMT UBER *EQIX interesting; seems undervalued at first glance.

0 · Reply

notreload_ai Nov. 13 at 5:09 PM

$HIMS , $DGX , $LH ... Hims & Hers Health launches lab testing with Quest Diagnostics, offering affordable biomarker tests and personalized health plans as part of its preventive care expansion. https://notreload.xyz/hims-launches-affordable-lab-testing/

0 · Reply

NVDAMillionaire Nov. 3 at 6:46 PM

$DGX Outstanding article that hits the mark on DGX's current state. So if you want to refresh your DGX insights or learn about DGX from scratch, this is a must read. https://beyondspx.com/quote/DGX/analysis/quest-diagnostics-accelerating-growth-with-advanced-diagnostics-and-strategic-market-capture-dgx

0 · Reply

Halo202 Nov. 2 at 9:47 PM

$DGX $180+ by Friday

0 · Reply

Quest Diagnostics Incorporated (DGX) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Dec 1, 2025, 8:30 AM EST - 4 days ago

Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Across the United States

Nov 14, 2025, 1:11 PM EST - 20 days ago

Quest Diagnostics Incorporated (DGX) Presents at 7th Annual Healthcare Symposium Transcript

Nov 14, 2025, 10:31 AM EST - 20 days ago

Digi Power X Inc. (DGX:CA) Q3 2025 Earnings Call Transcript

DGXX

Nov 12, 2025, 12:15 PM EST - 22 days ago

Daily Dividend Report: ADP, Agree Realty, Group 1, DGX, Aflac

ADP ADC AFL GPI

Nov 11, 2025, 4:22 PM EST - 23 days ago

Quest Diagnostics Declares Quarterly Cash Dividend

Nov 3, 2025, 4:09 PM EST - 4 weeks ago

Quest Diagnostics to Speak at Citi's 2025 Global Healthcare Conference

Oct 27, 2025, 7:45 AM EDT - 5 weeks ago

New Study Demonstrates Accuracy of Two Quest AD-Detect® Tests for Alzheimer's Disease Diagnosis

Oct 22, 2025, 3:10 PM EDT - 6 weeks ago

Quest Diagnostics: Strong Q3, Steady (Not Spectacular) Growth Ahead

Oct 22, 2025, 1:19 PM EDT - 6 weeks ago

Quest Diagnostics Analysts Increase Their Forecasts After Q3 Earnings

Oct 21, 2025, 11:54 AM EDT - 6 weeks ago

Quest Diagnostics Incorporated (DGX) Q3 2025 Earnings Call Transcript

Oct 21, 2025, 7:16 AM EDT - 6 weeks ago

Quest Diagnostics raises annual profit and revenue forecasts on lab test demand

Oct 21, 2025, 6:45 AM EDT - 6 weeks ago

Quest Diagnostics Reports Third Quarter 2025 Financial Results; Raises Guidance for Full Year 2025

Oct 6, 2025, 12:49 AM EDT - 2 months ago

Quest Diagnostics: Investing In Healthcare's Future Today

Sep 29, 2025, 7:07 PM EDT - 2 months ago

Quest Diagnostics Incorporated (DGX) Presents at Jefferies 2025 Healthcare Services Conference Transcript

Sep 25, 2025, 10:00 AM EDT - 2 months ago

Quest Diagnostics to Release Third Quarter 2025 Financial Results on October 21, 2025

Sep 24, 2025, 8:05 AM EDT - 2 months ago

Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant's Shield™ Blood-based Screening Test in the United States

Sep 23, 2025, 7:07 AM EDT - 2 months ago

Quest Diagnostics to Improve Laboratory Testing Experience with Industry-First Epic Collaboration

Sep 22, 2025, 8:07 AM EDT - 2 months ago

Haystack Oncology and Rutgers Cancer Institute Collaborate in a Clinical Study to Examine Haystack MRD as a Guide for Post-Surgical Treatment for Lung Cancer

Sep 18, 2025, 9:00 AM EDT - 2 months ago

WHOOP to Bring Clinical Lab Testing from Quest Diagnostics to the WHOOP App

Sep 15, 2025, 6:21 PM EDT - 2 months ago

Quest Diagnostics to Speak at the Jefferies Healthcare Services Conference

Sep 10, 2025, 1:16 PM EDT - 3 months ago

Quest Diagnostics Incorporated (DGX) Presents At Baird Global Healthcare Conference 2025 Transcript

Sep 4, 2025, 7:00 PM EDT - 3 months ago

Quest Diagnostics: A Solid Investment or a Risky Bet?

Sep 4, 2025, 9:32 AM EDT - 3 months ago

Quest Diagnostics Launches Advanced Pharmacogenomics (PGx) Offering

Sep 2, 2025, 6:27 AM EDT - 3 months ago

Fentanyl Positivity Is More Than Seven Times Higher in Random Tests vs. Pre-Employment Drug Screening, Finds 2025 Quest Diagnostics Drug Testing Index

Aug 26, 2025, 9:00 AM EDT - 3 months ago

Corewell Health and Quest Diagnostics to Enter into Joint Venture Providing Enhanced Laboratory Services in Michigan

Aug 25, 2025, 8:52 AM EDT - 3 months ago

FDA Grants Breakthrough Device Designation for Haystack MRD Circulating Tumor DNA Test from Quest Diagnostics

Aug 15, 2025, 6:14 PM EDT - 3 months ago

Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference

Aug 7, 2025, 9:08 AM EDT - 4 months ago

Mass General Brigham Launches Two Clinical Trials to Study Haystack MRD ctDNA as Guide for Post-surgical Treatment for Two Cancer Types

Aug 5, 2025, 8:33 AM EDT - 4 months ago

Quest Diagnostics Completes Acquisition of Clinical Testing Assets from Fresenius Medical Care

Jul 29, 2025, 8:52 AM EDT - 4 months ago

Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing

PACB

Jul 22, 2025, 5:02 PM EDT - 4 months ago

Quest Diagnostics Raises 2025 Guidance

Jul 22, 2025, 2:19 PM EDT - 4 months ago

Quest Diagnostics Boosts Its 2025 Outlook

Jul 22, 2025, 1:10 PM EDT - 4 months ago

Quest Diagnostics Raises Outlook, But Warns Of Tariff And Medicare Act Risks

Jul 22, 2025, 12:22 PM EDT - 4 months ago

Quest Diagnostics Incorporated (DGX) Q2 2025 Earnings Call Transcript

Jul 22, 2025, 7:17 AM EDT - 4 months ago

Quest Diagnostics raises annual forecasts on strong diagnostic testing demand

Jul 22, 2025, 6:47 AM EDT - 4 months ago

Quest Diagnostics Reports Second Quarter 2025 Financial Results; Raises Guidance for Full Year 2025

Jul 15, 2025, 7:57 AM EDT - 5 months ago

Quest Diagnostics Introduces Testing for Oropouche Virus

Jul 15, 2025, 7:36 AM EDT - 5 months ago

Quest Diagnostics: Buy Into Future Patient Demand, At An Undervalued Price Today

Jul 9, 2025, 8:24 AM EDT - 5 months ago

Quest Diagnostics to Offer FDA-Cleared Fujirebio Blood Test for Alzheimer's Disease

Jun 25, 2025, 9:07 AM EDT - 5 months ago

Quest Diagnostics Releases 2024 Corporate Responsibility Report

Jun 23, 2025, 10:52 AM EDT - 5 months ago

Quest Diagnostics to Release Second Quarter 2025 Financial Results on July 22, 2025

Jun 10, 2025, 8:03 AM EDT - 6 months ago

Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology

May 20, 2025, 8:52 AM EDT - 7 months ago

More Americans Know Their Streaming Platform Passwords by Heart Than Their Cholesterol Score, New Survey Reveals

May 16, 2025, 1:11 PM EDT - 7 months ago

Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference

May 13, 2025, 6:03 AM EDT - 7 months ago

Oncologists Report Seeing More Advanced Cancers and Say Current Tests Are Not Catching Cancer Recurrence Early Enough, New Quest Diagnostics Report Finds

May 3, 2025, 4:26 AM EDT - 7 months ago

Quest Diagnostics: A Leader But Waiting For Better Price

Apr 23, 2025, 1:17 PM EDT - 8 months ago

These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Q1 Earnings

Apr 22, 2025, 12:09 PM EDT - 8 months ago

Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence

Apr 22, 2025, 11:39 AM EDT - 8 months ago

Quest Diagnostics Incorporated (DGX) Q1 2025 Earnings Call Transcript

BillionerOfKing Dec. 3 at 3:04 AM

0 · Reply

Trade2Win2019 Nov. 24 at 11:21 PM

$DGX good short idea right here 🐻📉📉📉🩸

0 · Reply

OfficialStocktwitsUser Nov. 24 at 2:57 PM

0 · Reply

ZacksResearch Nov. 24 at 2:13 PM

0 · Reply

ZacksResearch Nov. 24 at 1:13 PM

0 · Reply

SPYmyQQQ Nov. 21 at 7:32 PM

🎯 Target Hit 🏁 📨 From Nov 11, 2025 🏛️ $DGX 💵 Entry: $188.8800 ✅ Exit: $193.4320 💰 P/L: +2.41% 👉 FREE TRIAL! spymyqqq/join/

0 · Reply

gaineous Nov. 19 at 3:46 PM

Bullish for 2026 Complete Conviction $AMT $ODD $ONDS $YOU $DGX Above Ave Conviction ATEC DOCU ZM Forever Holds AXP EXPE WMT UBER *EQIX interesting; seems undervalued at first glance.

0 · Reply

notreload_ai Nov. 13 at 5:09 PM

0 · Reply

NVDAMillionaire Nov. 3 at 6:46 PM

0 · Reply

Halo202 Nov. 2 at 9:47 PM

$DGX $180+ by Friday

0 · Reply

OfficialStocktwitsUser Oct. 31 at 12:17 PM

$DGX RSI: 36.45, MACD: -1.2211 Vol: 4.17, MA20: 182.43, MA50: 182.13 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

SuperGreenToday Oct. 31 at 11:53 AM

$DGX Share Price: $175.84 Contract Selected: Feb 20, 2026 $175 Calls Buy Zone: $7.61 – $9.40 Target Zone: $12.22 – $14.94 Potential Upside: 52% ROI Time to Expiration: 111 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

prismmarketview Oct. 27 at 6:38 PM

(NYSE: $DGX) Quest Diagnostics reported its AD-Detect Alzheimer’s blood tests show 91% sensitivity and specificity, matching more invasive methods for identifying brain markers. https://prismmarketview.com/quest-diagnostics-posts-strong-study-results-for-its-ad-detect-alzheimers-blood-tests/

0 · Reply

Bazzzigar Oct. 24 at 10:59 PM

$DGX hold long term

0 · Reply

Bazzzigar Oct. 24 at 6:23 PM

$DGX few more

0 · Reply

Small_time_trader Oct. 22 at 7:36 PM

$DGX Don’t sweat PAMA If PAMA is not delayed, many smaller labs instantly would be non - profitable and close their doors, big commercial labs like DGX would swoop in and grab the work. most likely Pama will continue to be pushed out until substantial changes are made to the pieces impacting laboratory medicine. Either way DGX wins

0 · Reply

JarvisFlow Oct. 22 at 4:59 PM

Barclays has adjusted their stance on Quest Diagnostics ( $DGX ), setting the rating to Equal-Weight with a target price of 190 → 195.

0 · Reply

Bazzzigar Oct. 22 at 3:13 PM

$DGX sector up

0 · Reply

JarvisFlow Oct. 22 at 2:09 PM

Truist Securities updates rating for Quest Diagnostics ( $DGX ) to Hold, target set at 195 → 205.

0 · Reply

JarvisFlow Oct. 21 at 8:57 PM

Leerink Partners has updated their rating for Quest Diagnostics ( $DGX ) to Outperform with a price target of 210.

0 · Reply

JarvisFlow Oct. 21 at 8:39 PM

Jefferies updates rating for Quest Diagnostics ( $DGX ) to Buy, target set at 200 → 215.

0 · Reply

JarvisFlow Oct. 21 at 8:37 PM

Jefferies has updated their rating for Quest Diagnostics ( $DGX ) to Buy with a price target of 200.

0 · Reply

Market Cap	20.31B
Revenue (ttm)	9.87B
Net Income (ttm)	871.00M
EPS (ttm)	N/A
PE Ratio	18.90
Forward PE	18.65
Profit Margin	8.82%
Debt to Equity Ratio	0.78

Volume	1,044,861
Avg Vol	1,112,904
Day's Range	N/A - N/A
Shares Out	111.24M
Stochastic %K	17%
Beta	0.62
Analysts	Sell
Price Target	$198.76